We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.61B
AUM Growth
+$36.4M
Cap. Flow
+$97.7M
Cap. Flow %
6.05%
Top 10 Hldgs %
61.46%
Holding
387
New
81
Increased
131
Reduced
147
Closed
19

Top Buys

Rank Stock Value
1
ASX icon
ASE Group
ASX
+$22.6M
2
MSFT icon
Microsoft
MSFT
+$12.4M
3
AAPL icon
Apple
AAPL
+$9.73M
4
NVDA icon
NVIDIA
NVDA
+$9.56M
5
AMZN icon
Amazon
AMZN
+$6.91M

Top Sells

Rank Stock Value
1
SE icon
Sea Limited
SE
+$20.8M
2
AMD icon
Advanced Micro Devices
AMD
+$16.3M
3
TSM icon
TSMC
TSM
+$7.3M
4
PDD icon
Pinduoduo
PDD
+$2.71M
5
WB icon
Weibo
WB
+$2.43M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 40.2%
2 Technology 29.79%
3 Communication Services 9.9%
4 Healthcare 5.71%
5 Real Estate 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDW icon
151
CDW
CDW
$18.5B
$575K 0.04%
2,249
-13
-0.6% -$3.09K
IBN icon
152
ICICI Bank
IBN
$107B
$574K 0.04%
+21,719
New +$542K
MCO icon
153
Moody's
MCO
$89.2B
$560K 0.03%
+1,425
New +$549K
DDOG icon
154
Datadog
DDOG
$85.1B
$549K 0.03%
4,440
-1,169
-21% -$147K
CPRT icon
155
Copart
CPRT
$30.5B
$542K 0.03%
9,364
-130
-1% -$6.68K
MRVL icon
156
Marvell Technology
MRVL
$195B
$513K 0.03%
7,231
-195
-3% -$13.4K
ANSS
157
DELISTED
Ansys
ANSS
$504K 0.03%
1,452
-37
-2% -$12.5K
EXAS
158
DELISTED
Exact Sciences
EXAS
$498K 0.03%
7,218
-203
-3% -$12.8K
VKTX icon
159
Viking Therapeutics
VKTX
$3.75B
$495K 0.03%
6,038
-16,157
-73% -$719K
MSI icon
160
Motorola Solutions
MSI
$80.4B
$488K 0.03%
1,376
-26
-2% -$8.56K
ROST icon
161
Ross Stores
ROST
$73.3B
$488K 0.03%
3,325
-69
-2% -$9.88K
CRNX icon
162
Crinetics Pharmaceuticals
CRNX
$9B
$480K 0.03%
10,248
-2,821
-22% -$110K
WDAY icon
163
Workday
WDAY
$50.6B
$477K 0.03%
1,748
-1,836
-51% -$523K
TREX icon
164
Trex
TREX
$4.66B
$475K 0.03%
+4,763
New +$424K
EXEL icon
165
Exelixis
EXEL
$13.5B
$463K 0.03%
19,512
-2,320
-11% -$51.6K
CYTK icon
166
Cytokinetics
CYTK
$10B
$462K 0.03%
6,591
-7,494
-53% -$580K
CAMT icon
167
Camtek
CAMT
$6.33B
$462K 0.03%
5,516
-3,111
-36% -$245K
DYN icon
168
Dyne Therapeutics
DYN
$4.68B
$462K 0.03%
+16,275
New +$368K
ODFL icon
169
Old Dominion Freight Line
ODFL
$41.2B
$457K 0.03%
2,084
-34
-2% -$7.09K
BBIO icon
170
BridgeBio Pharma
BBIO
$15B
$455K 0.03%
14,711
-58
-0.4% -$1.97K
MDGL icon
171
Madrigal Pharmaceuticals
MDGL
$12.3B
$453K 0.03%
1,698
-608
-26% -$143K
SRPT icon
172
Sarepta Therapeutics
SRPT
$2.2B
$451K 0.03%
3,485
-2,034
-37% -$249K
CP icon
173
Canadian Pacific Kansas City
CP
$82.7B
$450K 0.03%
+5,099
New +$428K
KRYS icon
174
Krystal Biotech
KRYS
$10.4B
$449K 0.03%
2,522
-1,973
-44% -$274K
RYTM icon
175
Rhythm Pharmaceuticals
RYTM
$7.38B
$448K 0.03%
10,333
+3,800
+58% +$166K

Similar funds

E Fund Management's Q1 2024 Portfolio in Review

As of Q1 2024, E Fund Management held 387 positions worth $1.61B, up 2.3% from $1.58B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

E Fund Management deployed $97.7M of net new capital in Q1 2024, opening 81 new positions and adding to 131 existing holdings. Its largest new stake was ASE Group: 2,300,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 50% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Sea Limited, an estimated $20.8M trimmed.

  • E Fund Management's largest Q1 2024 buy was ASE Group: 2,300,000 shares worth $25.3M.
  • E Fund Management added most to Microsoft in Q1 2024, an estimated $12.4M increase.
  • E Fund Management's biggest Q1 2024 reduction was Sea Limited, cutting an estimated $20.8M.
  • E Fund Management fully exited Hesai Group in Q1 2024, selling an estimated $1.52M.
  • E Fund Management's ten largest holdings make up 61% of its $1.61B portfolio in Q1 2024.
  • E Fund Management opened 81 new positions and closed 19 in Q1 2024.
  • E Fund Management's portfolio value rose 2.3% quarter-over-quarter to $1.61B.

Based on E Fund Management's 13F filing for Q1 2024, filed 13 May 2024.